Side-by-side comparison of AI visibility scores, market position, and capabilities
Real-time expense management platform with credit card integrations and accounting sync. Bangalore India / San Jose CA, raised $31M+.
Fyle is a real-time expense management platform that differentiates through deep integration with corporate credit cards from any bank and direct sync with accounting software, giving finance teams live visibility into employee spending without waiting for month-end reconciliation. Founded in 2016 and dual-headquartered in Bangalore, India and San Jose, California, Fyle has raised more than $31 million from investors including Insight Partners and Pravega Ventures. The platform is designed to work with existing corporate cards rather than requiring customers to switch to a proprietary card, lowering adoption friction significantly.\n\nFyle's architecture connects directly to the card networks to receive real-time transaction data, then automatically prompts employees via SMS or email to attach receipts and categorize expenses at the moment of purchase. This real-time approach means expense reports are continuously updated rather than compiled manually at month-end, reducing the reconciliation workload and improving policy compliance. The platform integrates bidirectionally with QuickBooks Online, Xero, NetSuite, Sage Intacct, and other accounting systems, pushing coded expense data to the correct accounts automatically.\n\nFyle serves small and mid-market businesses that want modern expense management without switching their banking or corporate card relationships. The company's card-agnostic positioning sets it apart from competitors like Brex, Ramp, and the Expensify Card that require customers to use the vendor's own payment card. Fyle competes with Expensify, Zoho Expense, and Divvy in the SMB and lower mid-market, and has seen strong adoption among accounting firms and their client portfolios.
a2z Radiology AI raised $20M in 2025 for its whole-body AI that simultaneously screens for 24+ conditions across CT scans — from incidental cancers to cardiovascular risk — in a single automated read.
a2z Radiology AI has developed a whole-body CT analysis platform that simultaneously screens for over 24 medical conditions across a single CT scan, including incidental cancers, coronary artery disease, aortic aneurysm, bone density loss, and organ abnormalities. The AI acts as a second reader that radiologists can use to catch incidental findings that fall outside the primary reason for a scan — a major source of missed diagnoses.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.